FIELD: pharmacology.
SUBSTANCE: antiangiogenic drug contains dimeric macrocyclic tannin isolated from shoots and inflorescences of Chamerion angustifolium, with C68H48O44 composition as an active substance, with a molecular weight of 1568.1518 of the following formula:
.
EFFECT: pronounced antiangiogenic and antitumour activity.
6 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ISOLATING THE SUM OF TANNINS USED TO OBTAIN THE SUBSTANCE OF THE ANTICANCER DRUG "HANEROL" FROM NARROW-LEAVED FIREWEED (IVAN TEA) (CHAMAENERION ANGUSTIFOLIUM (L.) SCOP.) | 2020 |
|
RU2750730C1 |
COMPLEX ANTIANGIOGENIC AND HYPOXIA-TARGETED ANTITUMOR AGENT | 2022 |
|
RU2804771C1 |
INDOLOCARBAZOLE DERIVATIVE BLOCKING TUMOUR VASCULOGENIC MIMICRY | 2014 |
|
RU2557554C1 |
TUMOUR THERAPY AGENT | 2019 |
|
RU2726801C1 |
APPLICATION OF HUMAN SKIN MELANOMA CELL LINE mel Cher AS POSITIVE MODEL OF VASCULOGENIC MIMICRY | 2009 |
|
RU2404243C1 |
COMPLEX ANTI-TUMORAL PRODUCT | 2020 |
|
RU2751776C2 |
FUSED PROTEIN WITH EFFECT OF ANGIOGENESIS INHIBITOR | 2008 |
|
RU2372354C1 |
HYDROXAMIC ACIDS, 4-AMINOQUINAZOLINE DERIVATIVES WITH ANTITUMOR ACTIVITY | 2022 |
|
RU2802463C1 |
ANTIANGIOGENIC MEDICINAL AGENT AND METHOD OF ITS PRODUCTION | 2009 |
|
RU2404783C1 |
APPLICATION OF MEDICATIONS, BINDING EDG-RECEPTOR, IN TREATMENT OF CANCER DISEASE | 2008 |
|
RU2426555C2 |
Authors
Dates
2017-10-24—Published
2016-12-22—Filed